Skip to main content
OpenTrials
Completed

NCT Number: NCT05872646

The Effect of Cognitive Functions on Upper Extremity Functionality in Parkinson's Patients

Parkinson's Disease (PD), first described by James Parkinson in 1817, is a progressive movement disorder that develops mainly as a result of the destruction of nigrostriatal dopaminergic neurons. The aim of our study is to determine the effect of cognitive functions on upper extremity functionality in individuals with Parkinson's Disease.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pamukkale Unıversity

Denizli, 20000, Turkey (Türkiye)

About this study

Parkinson's Disease (PD), first described by James Parkinson in 1817, is a progressive movement disorder that develops mainly as a result of the destruction of nigrostriatal dopaminergic neurons. Involvement of nigrostriatal dopaminergic neurons is associated with the motor manifestations of the disease. The most common of these symptoms are; resting tremor, bradykinesia, rigidity and balance disorder. However, non-motor symptoms related to the involvement of nervous system structures other than the dopaminergic nigrostriatal system can be observed in PD. However, due to the predominance of motor symptoms in PD, it took many years to notice cognitive changes. Traditionally, cognitive impairments in PD have been expected to occur in the advanced stages of the disease. However, cognitive impairments in the early stages are reported in approximately 30-35% of patients. Cognitive dysfunction is defined in PD, ranging from mild impairments in certain cognitive domains to severe dementia. Cognitive impairment primarily affects executive and visuospatial functions, and memory is secondarily affected.

Executive functions are higher cognitive processes that use and modify information from many cortical sensory systems in the fore and hindbrain areas to modulate and teach behavior. The frontal cortex, especially the prefrontal cortex and its striatal connections are very important neuroanatomical regions for executive functions. The relationship between the effects of cognition and motor performance and parameters in groups such as the elderly, PD and Alzheimer's patients in which these centers are affected has been an issue that has attracted the attention of many researchers. Most of the studies have focused on the lower extremity performance of cognition. However , it has been reported that cognition has positive effects on upper extremity performance and early acquired upper extremity skills have positive effects on cognitive performance .

The aim of our study is to determine the effect of cognitive functions on upper extremity functionality in individuals with Parkinson's Disease.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having a diagnosis of Parkinson's Disease.
  • Not having hearing and vision problems.
  • To be able to take the commands required for the manual dexterity tests.
  • Agree to participate in the study.

Exclusion criteria

  • Having undergone musculoskeletal surgery for the upper extremity.
  • Having vision and hearing problems.
  • Having an additional disease that may affect cognitive tests.

Treatment and study plan

Clinical assessment

Diagnostic Test

clinical staging

Other names: modifiye hoehn yahr

Primary outcomes

  1. Modified Hoehn Yahr Scale

    Time frame: 1 year

    Used for clinical staging of Parkinson's disease

  2. Unified Parkinson's Disease Rating Scale

    Time frame: 1 year

    Used for the evaluation of clinical manifestations of Parkinson's disease

  3. Parkinson's Disease Questionnaire-PDQ 39

    Time frame: 1 year

    Used to assess the quality of life of Parkinson's patients

Secondary outcomes

  1. Stroop Test

    Time frame: 1 year

    measures the selective attention ability of individuals

  2. Wechsler Memory Scale-Revised

    Time frame: 1 year

    To assess attention, learning, memory and working memory in individuals aged 16-89

  3. Dexterity Questionnaire-24

    Time frame: 1 year

    To assess manuel dexterity

  4. Nine Hole Peg Test

    Time frame: 1 year

    To assess manuel dexterity

Sponsors and collaborators

Lead sponsor

Pamukkale University

Other

Registry information

Important dates

Study start
2018
Primary completion
2023
Study completion
2023
First posted
May 24, 2023
Registry last updated
May 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.